Chester County News and Community Website
WASHINTON, D.C. — The U.S. Food and Drug Administration (FDA) recenlty announced the launch of its new Human Foods Program, marking the largest reorganization in the agency’s modern history. This …
FDA Launches Human Foods Program Amid Major Agency Reorganization Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced a pivotal development as the FDA lifted the clinical hold on its investigational drug application for OCU200.
FDA Greenlights Ocugen’s Revolutionary Eye Treatment: What It Means for Vision Care Read More
WASHINGTON, D.C. — The Food and Drug Administration has announced a voluntary recall by Youngstown Grape Distributors Inc., a co-manufacturer for Happy Moose Juice. The recall affects specific lots of …
FDA Announces Recall of Happy Moose Juice Products Over Safety Concerns Read More
WASHINGTON, D.C. — The United States Food and Drug Administration has issued a crucial announcement concerning a voluntary correction by Philips Respironics regarding their Trilogy Evo series ventilators. This correction addresses …
FDA Alerts Public to Philips Respironics Ventilator Correction Over In-Line Nebulizer Concerns Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced that JLunds & Byerlys is conducting a voluntary recall of approximately 500 containers of its L&B Lone Star Dip due …
Mold Alert: Urgent Recall of L&B Lone Star Dip! Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced a precautionary recall by Jack and the Green Sprouts, Inc., based in River Falls, Wisconsin. This recall pertains to their …
FDA Issues Urgent Recall on Alfalfa Sprouts Due to Listeria Concerns Read More
WASHINGTON, D.C. — In a significant food safety alert, the Food and Drug Administration (FDA) has announced a recall of Hammond’s Dark Chocolate Filled Mini Waffle Cones. This action comes after …
Urgent Recall: Hammond’s Candies Warns of Undeclared Milk in Chocolate Products Read More
WAYNE, PA — Palvella Therapeutics, Inc. has been awarded up to $2.6 million by the FDA’s Office of Orphan Products Development to support its Phase 3 SELVA trial. This trial investigates …
Palvella Therapeutics Secures $2.6 Million FDA Grant for Phase 3 Trial Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has unveiled the Savara Early Access Program, a significant initiative aimed at providing molgramostim to patients suffering from autoimmune pulmonary alveolar proteinosis (aPAP). This …
Savara Inc. Launches Early Access Program for Rare Lung Disease Treatment Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. This innovative medication marks a significant …
FDA Approves Cobenfy, Pioneering New Approach to Schizophrenia Treatment Read More